Drug Use Investigation (DUI) of YazFlex for Endometriosis-associated Pelvic Pain and/or Dysmenorrhea
Phase of Trial: Phase IV
Latest Information Update: 27 Jul 2017
At a glance
- Drugs Drospirenone/ethinylestradiol (Primary)
- Indications Dysmenorrhoea; Endometriosis
- Focus Adverse reactions
- Sponsors Bayer
- 21 Jul 2017 Status changed from not yet recruiting to recruiting.
- 19 Jun 2017 Planned initiation date changed from 15 Jun 2017 to 29 Jun 2017.
- 19 May 2017 Planned initiation date changed from 1 May 2017 to 15 Jun 2017.